Systems biology: personalized medicine for the future?
暂无分享,去创建一个
[1] L. Hood,et al. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. , 2012, New biotechnology.
[2] Muin J Khoury,et al. A population approach to precision medicine. , 2012, American journal of preventive medicine.
[3] Hanlee P. Ji,et al. Corrigendum: Performance comparison of whole-genome sequencing platforms , 2012, Nature Biotechnology.
[4] A. Bashashati,et al. Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer , 2012, Genome research.
[5] Giovanni Parmigiani,et al. The Predictive Capacity of Personal Genome Sequencing , 2012, Science Translational Medicine.
[6] A. Ashworth,et al. A whole‐genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor‐negative and ‐positive breast cancers , 2012, The Journal of pathology.
[7] Alexander A. Morgan,et al. Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes , 2012, Proceedings of the National Academy of Sciences.
[8] Richard B. Schwab,et al. Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens , 2012, Nucleic acids research.
[9] Alexander A. Morgan,et al. Type 2 Diabetes Risk Alleles Demonstrate Extreme Directional Differentiation among Human Populations, Compared to Other Diseases , 2012, PLoS genetics.
[10] Hugo Y. K. Lam,et al. Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes , 2012, Cell.
[11] Huanming Yang,et al. Single-Cell Exome Sequencing and Monoclonal Evolution of a JAK2-Negative Myeloproliferative Neoplasm , 2012, Cell.
[12] Huanming Yang,et al. Single-Cell Exome Sequencing Reveals Single-Nucleotide Mutation Characteristics of a Kidney Tumor , 2012, Cell.
[13] Y. Lee,et al. Gene-Gene and Gene-Environmental Interactions of Childhood Asthma: A Multifactor Dimension Reduction Approach , 2012, PloS one.
[14] Xi-jun Wang,et al. Future perspectives of personalized medicine in traditional Chinese medicine: a systems biology approach. , 2012, Complementary therapies in medicine.
[15] David T. W. Jones,et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.
[16] Y. Louzoun,et al. Rep‐Seq: uncovering the immunological repertoire through next‐generation sequencing , 2012, Immunology.
[17] David T. W. Jones,et al. Genome Sequencing of Pediatric Medulloblastoma Links Catastrophic DNA Rearrangements with TP53 Mutations , 2012, Cell.
[18] Euan A Ashley,et al. Performance comparison of whole-genome sequencing platforms , 2011, Nature Biotechnology.
[19] P. D. Rijk,et al. Optimized filtering reduces the error rate in detecting genomic variants by short-read sequencing , 2011, Nature Biotechnology.
[20] Inyoul Lee,et al. Extracellular microRNA: a new source of biomarkers. , 2011, Mutation research.
[21] S. Szefler,et al. New insights into asthma pathogenesis and treatment. , 2011, Current opinion in immunology.
[22] Xuerui Yang,et al. An Extensive MicroRNA-Mediated Network of RNA-RNA Interactions Regulates Established Oncogenic Pathways in Glioblastoma , 2011, Cell.
[23] Hugo Y. K. Lam,et al. Performance comparison of exome DNA sequencing technologies , 2011, Nature Biotechnology.
[24] Omar E. Cornejo,et al. Phased Whole-Genome Genetic Risk in a Family Quartet Using a Major Allele Reference Sequence , 2011, PLoS genetics.
[25] Juliane C. Dohm,et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia , 2011, Nature.
[26] David R. Murdock,et al. Whole-Genome Sequencing for Optimized Patient Management , 2011, Science Translational Medicine.
[27] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[28] Hidenori Ojima,et al. High-resolution characterization of a hepatocellular carcinoma genome , 2011, Nature Genetics.
[29] Li Ding,et al. Identification of a novel TP53 cancer susceptibility mutation through whole-genome sequencing of a patient with therapy-related AML. , 2011, JAMA.
[30] Trey Ideker,et al. Boosting Signal-to-Noise in Complex Biology: Prior Knowledge Is Power , 2011, Cell.
[31] A. Darzi,et al. Gut microbiome-host interactions in health and disease , 2011, Genome Medicine.
[32] M. Orešič,et al. Drug metabolome of the simvastatin formed by human intestinal microbiota in vitro. , 2011, Molecular bioSystems.
[33] Gary An,et al. Translational systems biology of inflammation: potential applications to personalized medicine. , 2010, Personalized medicine.
[34] Benito Munoz,et al. Towards patient-based cancer therapeutics , 2010, Nature Biotechnology.
[35] Alexander A. Morgan,et al. Clinical assessment incorporating a personal genome , 2010, The Lancet.
[36] P. Shannon,et al. Analysis of Genetic Inheritance in a Family Quartet by Whole-Genome Sequencing , 2010, Science.
[37] Stephen L. Hauser,et al. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis , 2010, Nature.
[38] Mark Gerstein,et al. Personal genome sequencing: current approaches and challenges. , 2010, Genes & development.
[39] E. Birney,et al. A small cell lung cancer genome reports complex tobacco exposure signatures , 2009, Nature.
[40] Tom Royce,et al. A comprehensive catalogue of somatic mutations from a human cancer genome , 2010, Nature.
[41] Dmitry Pushkarev,et al. Single-molecule sequencing of an individual human genome , 2009, Nature Biotechnology.
[42] Mark Gerstein,et al. Personal phenotypes to go with personal genomes , 2009, Molecular systems biology.
[43] Massimo Loda,et al. Investigative pathology: leading the post-genomic revolution , 2012, Laboratory Investigation.
[44] R. Sékaly,et al. Dissecting the HIV-specific immune response: a systems biology approach. , 2012, Current opinion in HIV and AIDS.
[45] M. Dietel,et al. Personalized cancer medicine and the future of pathology , 2011, Virchows Archiv.